tbuckley/cabot-search huggingface dataset:
Membership of Committees on Education (as of July 1, 1993)
Journal: JAMA (1993)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Intrapancreatic Obstruction
Authors: Charles W. Wainwrigiit
Journal: New England Journal of Medicine (1951)

IT CERTAINLY seems fair to say that Opie's1 explanation in 1901 of the mode of production of acute hemorrhagic pancreatitis has influenced opinion concerning this condition to the present time. He demonstrated at autopsy a common opening into the duodenum of the bile duct and the pancreatic duct in a patient who had died of acute hemorrhagic pancreatitis, and the presence of a biliary calculus in the ampulla of Vater. This converted the bile duct and the pancreatic duct into a common channel, permitting bile to enter the pancreatic duct. This demonstration has associated biliary-tract disease with the production of . . .
Thomas Hodgkin and Hodgkin's disease. Two paradigms appropriate to medicine today
Authors: S. Hellman
Journal: JAMA (1991)

Thomas Hodgkin was an investigator whose contributions extended over a wide range of medicine. While he is known for Hodgkin's disease, this was not his major interest. That this is so has more to do with his successors than him. He had a highly committed social conscience and was outspoken in advocacy of his positions. This greatly limited his professional career. The history of Hodgkin's disease is one of hypothesis generation, which allowed for its effective treatment even without an understanding of its etiology, illustrating the approximate nature of scientific discovery and the importance of chance in historical attribution. Hodgkin, as a scientist, healer, and socially committed individual, embodied the many characteristics that are desirable for today's physician, while the evolution of knowledge about Hodgkin's disease and its treatment is an instructive model for future medical advances. (<i>JAMA</i>. 1991;265:1007-1010)
Beer Drinking in the Army.
Journal: JAMA (1899)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Lack of evidence of human herpesvirus 8 DNA sequences in HIV-negative patients with various lymphoproliferative disorders of the skin
Authors: N. DUPIN, N. FRANCK, V. CALVEZ, I. GORIN, M. GRANDADAM, J.-M. HURAUX, M. LEIBOWITCH, H. GUT, J.-P. ESCANDE
Journal: British Journal of Dermatology (1997)
Serial analysis of MLL‐AF4 chimeric message through successful bone marrow transplantation in a patient with t(4;11)‐positive infant‐ALL
Authors: Yasuhiro Tabata, Shigeyoshi Hibi, Hiroko Maruyama‐Tabata, Kentaro Tsunamoto, Shinjiro Todo, Tadashi Sawada, Takayuki Okamura, Keisei Kawa‐Ha, Shinsaku Imashuku
Journal: American Journal of Hematology (2000)

A 28-month-old girl with acute lymphoblastic leukemia (ALL) showing a t(4;11)(q21;q23) karyotype successfully underwent allogeneic bone marrow transplantation (BMT) at relapse.The chimeric MLL-AF4 message on her bone marrow (BM) specimens, examined by reverse transcriptase-polymerase chain reaction, was detectable at diagnosis, relapse, and just before BMT but became undetectable following BMT.She has since maintained complete remission.This observation suggests that detection of the chimeric message in BM may be useful to predict clinical outcome in patients with t(4;11) ALL.Am.
Lower GI tract - clinical
Authors: U Wildersmi, S Scheurer, J Hurlimaun, F Groal, H Halter, Motility Camiici, J Von Der Ohe, R Scolapio
Journal: Gut (1993)

Transport characteristics and modulation in response to stimuli varies betwien colonic segments.To assess segmental motility patterns in the transverse, descending and sigmoid colon under fasting and fed conditions, colonic moilit was _masured for 4h in 8 healthy volunteers (ages 21-28), using piezoresistive pressure transducers and a 6-channel datalogger (GastroscanR 6020, MSC, Switzerlamd).Three pairs of trans- ducers were spaced 25cm apart.Manometry catheters were positioned at colono- scopy, after preparation with only a small enema.Subjectswere gfreplacebo or cisapride 10mg tds for 3 days before manometry in a cross-over design.Meals and activities were standardised.For preiminary analysis, the area-under-the-cuve (AUC) of the motilitndices ofthepressurecordings(mmHg) werecompared between a lh fasting and lh fed period, with and without cisapride.Results: group median AUC (range) of the motility indices with and without cisapride in the fasting and fed periods are shown: iRNVERSE COLON SCNING COLON WIMID COLON | LACEBO CISAPRIDE LACEBO SAPRIDE LACEBO RDE .55(.46-.78) 1.66 (.45-1.1)0.44 (.24-.8) h.74 (.38-1.9)W.43 (.13-.74)F.48 (.27-1.7) 1.03 (.77-1.5)[1.11 (.7&1.6) 1.88 (3-2.0)V.21 (.85.2.8) b.61 (.34-1.8).79 (.18-3.0)vssngwfed <O.00 <0.01 p0.
Autonomic Hyperreflexia
Authors: W. W. Winternitz
Journal: JAMA (1970)

<h3>To the Editor.—</h3> Neider et al stated in their article "Autonomic Hyperreflexia in Urologic Surgery" (<b>213</b>: 867, 1970) that sympatholytic agents have been ineffective for the treatment of autonomic hyperreflexia. We have previously presented<sup>1</sup>two patients who responded to such agents, namely the α-adrenergic blocking agents phentolamine (Regitine) or phenoxybenzamine hydrochloride (Dibenzyline) or both. We proposed and demonstrated that doses larger than 5 mg of phentolamine might be needed to control the hypertensive paroxysms of autonomic hyperreflexia. In Nieder's patient the blood pressure decrease from 235/ 130 mm Hg to 190/110 mm Hg could have represented direct vasodilatation,<sup>2</sup>but it is also possible that a repeated or larger dose of phentolamine may have controlled the hypertension. We agree with the authors that in most cases the more permanent methods of management are unnecessary. We suggest that the use of α-adrenergic blocking agents will also reduce the need for
Recurrent Venous Thrombosis
Authors: Paul deR Kolisch
Journal: JAMA (1978)

<h3>To the Editor.—</h3> Dr Jack Hirsh's discussion of the management of recurrent venous thrombosis (240:284, 1978) struck a responsive chord by stating that "it is important to establish... recurrence by a repeated phlebogram or, preferably, by leg scanning using fibrinogen labeled with iodine 125." The key word here is "preferably." It is, unequivocally, most appropriate. No other method can offer what the fibrinogen<sup>125</sup>I scan enables one to do, that is, to start the study prospectively. If impending deep-vein thrombosis is suspected, phlebography (either by scintiscanning or by "conventional" radiography) has little to offer, whereas fibrinogen<sup>125</sup>I will localize in the thrombus when and if it forms. (As a matter of fact, preoperative injection of fibrinogen<sup>125</sup>I is recommended in cases where postoperative deep-vein thrombosis is likely to develop, eg, pelvic operations.) It is equally important to recognize that patient cooperation with fibrinogen<sup>125</sup>I scanning is
Narcolepsy
Authors: Vincent Zarcone
Journal: New England Journal of Medicine (1973)

IT is useful to divide the clinical problems associated with sleep into three general categories: the insomnias, the hypersomnias, and the episodic or intermittent sleep disorders. In this general classification the term hypersomnia refers to any condition involving excessive sleep and sleepiness or falling asleep. The hypersomniac process in narcolepsy is characterized by attacks of sleep often in circumstances that ordinarily are not at all conducive to sleepiness. It is this aspect that makes narcolepsy one of the most dramatic of the sleep disorders and that, together with a relatively high prevalence, has made it the most extensively studied. In . . .
A new model for predicting breast cancer risk in women with atypical hyperplasia.
Authors: Amy C. Degnim, V. Shane Pankratz, Stacey J Winham, William D Dupont, Robert A. Vierkant, Ryan D. Frank, Marlene H. Frost, Celine Vachon, Karthik Ghosh, Tina J. Hieken, Jodi M Carter, Tufia C. Haddad, Lori Denison, Daniel W. Visscher, Lynn C. Hartmann, Derek C Radisky
Journal: Journal of Clinical Oncology (2015)

2 Background: Women with atypical hyperplasia (AH) on breast biopsy have an aggregate increased risk of breast cancer (BC), but accurate personalized risk prediction is desirable to facilitate individual clinical management decisions. Currently used models provide poor BC risk prediction for women with AH. Our goal was to develop and validate an improved risk prediction model for women with AH. Methods: From a cohort of 13,538 women with benign breast disease from 1967-2001, pathology review confirmed 699 with AH. Clinical risk factors and histologic features of the tissue biopsy were recorded, and BC events were ascertained from study questionnaires, tumor registry, and review of medical records. Using a lasso approach, 23 variables were assessed for model inclusion. Lasso-identified features were then fit in a Cox regression model to estimate BC risk. Model discrimination was assessed with C-statistics in the model-building set and in a separate external validation set. Calibration was assessed by comparing observed to predicted breast cancer counts. Results: The model-building set comprised 699 women with 142 BC events (median follow-up 8.1 years), and the external validation set comprised 461 women with 114 BC events (median follow-up 11.4 years). The final model included three covariates: age at biopsy, age squared, and number of foci of AH. Model performance was good, with a C-statistic of 0.622 (SE = 0.027) in the model-building set and 0.594 (SE = 0.029) in the external validation set. The model is well-calibrated, with observed to expected numbers of BCs nearly equal across all post-biopsy follow-up years. Conclusions: We propose a new model for predicting BC risk in women with AH based on age at biopsy and number of foci of atypia. This model provides absolute risk estimates for women with AH, has good discriminatory ability, is well-calibrated, and validates in an external cohort.
An expansile lesion of the proximal ulna
Authors: J. A. Guzzetta
Journal: JAMA (1970)

Dr. Guy C. Hebert: This patient is a 10-year-old white girl admitted because of an aching pain in the left elbow of several weeks' duration. The patient first noted this pain after exercising at school. It was believed to be due to muscle strain but when it persisted, she was taken to her family physician and roentgenograms were obtained. There had been no previous bone pain, fracture, or trauma to this area. The patient's history and family history were non-contributory. The results of physical examination were normal except for mild tenderness to deep palpation in the medial forearm over the left ulna at its proximal extremity. There was no palpable mass. Findings from laboratory studies were within normal limits. <h3>Discussion</h3> Dr. Laurence L. Robbins: Dr. McNeill, would you please discuss this case? Dr. J. Malcolm McNeill: The roentgenograms (Figure) show an expanded lesion in the proximal ulna that has a
Lorenz Heister (1683-1758). Eighteenth century surgeon
Journal: JAMA (1967)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Tc-99m MDP Imaging in Hereditary Multiple Exostoses
Authors: JOSE M. RESTREPO, VICENTE J. CARIDE
Journal: Clinical Nuclear Medicine (2003)

Whole-body bone scintigraphy with Tc-99m MDP was performed as part of a metastatic workup in a patient with lung cancer. The patient also had a history of hereditary multiple exostoses (HME), a disease consisting of multiple osteochondromas. One of the complications of HME is malignant transformation of the osteochondromas into chondrosarcomas. Intense tracer uptake can be seen in both benign and malignant lesions, and thus bone scintigraphy is not used routinely in HME to differentiate between the two. However, as in this case, lack of intense tracer uptake in an osteochondroma virtually excludes malignant transformation.
Medical and nonmedical uses of anabolic-androgenic steroids. Council on Scientific Affairs
Journal: JAMA (1990)

Recent trends in the use, abuse, and diversion of steroids for nonmedical purposes illustrate a growing problem that not only imposes health risks but presents ethical dilemmas as well. Concern over the known adverse effects, the limited research into the long-term effects, and the ethics of engineering body size and performance through anabolic-androgenic steroid use has led to legislative, legal, and education responses. Increased penalties for distribution to minors and stricter controls in prescribing practices have been enacted through state legislation and federal initiatives. Government, some health professional organizations, and some sports groups have denounced the nonmedical use of anabolic-androgenic steroids and have developed materials to educate their members, other professionals, athletes, educators, and the public at large.
Telemedicine technology and clinical applications
Authors: D. A. Perednia
Journal: JAMA (1995)

TELEMEDICINE can be broadly defined as the use of telecommunications technologies to provide medical information and services. Although this definition includes medical uses of the telephone, facsimile, and distance education,<i>telemedicine</i>is increasingly being used as shorthand for remote electronic clinical consultation. Interest in the field has increased dramatically in the 1990s. State and federal allocations for telemedicine and related technologies are likely to exceed $100 million in fiscal 1994-1995.<sup>1</sup>At least 13 federal agencies, including the US Department of Commerce, Health Care Financing Administration (HCFA), Office of Rural Health Policy, and US Department of Defense, have begun telemedicine research and demonstration programs. Many states are using their own resources to build state-of-the-art telemedicine systems, some with capital investments exceeding $50 million. Faith in this technology is not universal, however. Depending on one's viewpoint, telemedicine may be seen as a valuable tool for providing badly needed specialty care services
PRELIMINARY EDUCATION FOR NURSES ENTERING TRAINING SCHOOLS.
Journal: JAMA (1903)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Index editorial board
Authors: Jeffrey Bernhard, Thomas Cropley, Karen Wiss, Michael Bigby, Jeffrey Callen, Louisville Kentucky, Luis Diaz, Chapel Hill, North Carolina, Jane Grant-Kels, Mark Lebwohl, New York, Mary Maloney, Alan Menter, Donald Miech, Scott Norton, Maryland Olsen, Amy Paller, Illinois Sharon, Ann Raimer, Thomas Ray, Iowa City, Iowa Stuart, J Salasche, Tucson Arizona, Martin Weinstock, Rhode Island, J Smith, Richard Dobson
Journal: Journal of the American Academy of Dermatology (2003)
INSANE ASYLUM INVESTIGATIONS.
Journal: JAMA (1889)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
IN BEHALF OF THE STOMACH TUBE
Journal: JAMA (1922)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
'Runner's Trots'
Authors: Richard N. Fogoros
Journal: JAMA (1980)

Derek Clayton, describing aftermath of his world record marathon run (<i>Runner's World</i>, May 1979, p 72). WITH the recent popularity of running, physicians should recognize various "abnormalities" that occur in healthy runners, either as physiological adaptations to physical training or as normal responses to extreme exertion. These include various bradyarrhythmias, left ventricular enlargement, proteinuria, and hematuria. The bradyarrhythmias, such as sinus bradycardia, Wenckebach or junctional rhythms, or first-degree atrioventricular block, are due to high parasympathetic tone in the athlete.<sup>1,2</sup>Left ventricular enlargement is thought to be a physiological adaptation to endurance training and does not represent a pathological disorder.<sup>3</sup>Proteinuria, which may be due to relative renal ischemia, is gone 48 hours after exercise.<sup>4</sup>Hematuria in runners may be due to superficial bladder trauma in most cases.<sup>5</sup> Conspicuously absent from the medical literature is the description of gastrointestinal (GI) symptoms experienced by many runners. These GI
Mapping of monilethrix to the type II keratin gene cluster at chromosome 12q13 in three new families, including one with variable expressivity
Authors: M.A. BIRCH-MACHIN, E. HEALY, R. TURNER, F. HALDANE, C.E. BELGAID, S. DARLINGTON, A.M. STEPHENSON, C. MUNRO, A.G. MESSENGER, J.L. REES
Journal: British Journal of Dermatology (1997)